Search research articles
Contact Us
Filters
Showing results (51-60 of 78) with videos related to
Page
of 8
Sort By:
Antimicrobial Agents and Chemotherapy
|
July 10, 2020
Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations
Catia Marzolini, Felix Stader, Marcel Stoeckle, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 12, 2024
Weight, Anthropometric and Metabolic Changes After Discontinuing Antiretroviral Therapy Containing Tenofovir Alafenamide in People With HIV
José Damas, Aline Munting, Jacques Fellay, et al.
International Journal of STD & AIDS
|
February 25, 2021
The association between depressive symptoms and neurocognitive impairment in people with well-treated HIV in Switzerland
Galia Santos, Isabella Locatelli, Mélanie Métral, et al.
Open Forum Infectious Diseases
|
July 16, 2019
Cross-Sectional and Cumulative Longitudinal Central Nervous System Penetration Effectiveness Scores Are Not Associated With Neurocognitive Impairment in a Well Treated Aging Human Immunodeficiency Virus-Positive Population in Switzerland
Galia M A Santos, Isabella Locatelli, Mélanie Métral, et al.
AIDS (London, England)
|
August 19, 2021
Neurocognitive course at 2-year follow-up in a Swiss cohort of people with well-treated HIV
José Damas, Bruno Ledergerber, Isaure Nadin, et al.
HIV Medicine
|
May 11, 2026
CHildren of the Cohort Study (CHOC): Exploring parenting desire among people living with HIV in Switzerland
Clara Merlin, José Damas, Olivier Nawej Tshikung, et al.
Viruses
|
November 4, 2020
HCV Genetic Diversity Can Be Used to Infer Infection Recency and Time since Infection
Louisa A Carlisle, Teja Turk, Karin J Metzner, et al.
The Lancet. HIV
|
March 6, 2017
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide coformulated with rilpivirine and emtricitabine in virally suppressed adults with HIV-1 infection: a randomised, double-blind, multicentre, phase 3b, non-inferiority study
Chloe Orkin, Edwin DeJesus, Moti Ramgopal, et al.
The Lancet. HIV
|
May 26, 2026
Trends in AIDS-defining illnesses among people living with HIV in clinical care in Europe: results from the EuroSIDA multicentre cohort study (2003-24)
Wendy P Bannister, Joanne Reekie, Lars Peters, et al.
Plos One
|
April 30, 2015
Boceprevir or Telaprevir Based Triple Therapy against Chronic Hepatitis C in HIV Coinfection: Real-Life Safety and Efficacy
Karin Neukam, Daniela I Munteanu, Antonio Rivero-Juárez, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 78) with videos related to
Sort By:
Page
of 8
Antimicrobial Agents and Chemotherapy
|
July 10, 2020
Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations
Catia Marzolini, Felix Stader, Marcel Stoeckle, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 12, 2024
Weight, Anthropometric and Metabolic Changes After Discontinuing Antiretroviral Therapy Containing Tenofovir Alafenamide in People With HIV
José Damas, Aline Munting, Jacques Fellay, et al.
International Journal of STD & AIDS
|
February 25, 2021
The association between depressive symptoms and neurocognitive impairment in people with well-treated HIV in Switzerland
Galia Santos, Isabella Locatelli, Mélanie Métral, et al.
Open Forum Infectious Diseases
|
July 16, 2019
Cross-Sectional and Cumulative Longitudinal Central Nervous System Penetration Effectiveness Scores Are Not Associated With Neurocognitive Impairment in a Well Treated Aging Human Immunodeficiency Virus-Positive Population in Switzerland
Galia M A Santos, Isabella Locatelli, Mélanie Métral, et al.
AIDS (London, England)
|
August 19, 2021
Neurocognitive course at 2-year follow-up in a Swiss cohort of people with well-treated HIV
José Damas, Bruno Ledergerber, Isaure Nadin, et al.
HIV Medicine
|
May 11, 2026
CHildren of the Cohort Study (CHOC): Exploring parenting desire among people living with HIV in Switzerland
Clara Merlin, José Damas, Olivier Nawej Tshikung, et al.
Viruses
|
November 4, 2020
HCV Genetic Diversity Can Be Used to Infer Infection Recency and Time since Infection
Louisa A Carlisle, Teja Turk, Karin J Metzner, et al.
The Lancet. HIV
|
March 6, 2017
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide coformulated with rilpivirine and emtricitabine in virally suppressed adults with HIV-1 infection: a randomised, double-blind, multicentre, phase 3b, non-inferiority study
Chloe Orkin, Edwin DeJesus, Moti Ramgopal, et al.
The Lancet. HIV
|
May 26, 2026
Trends in AIDS-defining illnesses among people living with HIV in clinical care in Europe: results from the EuroSIDA multicentre cohort study (2003-24)
Wendy P Bannister, Joanne Reekie, Lars Peters, et al.
Plos One
|
April 30, 2015
Boceprevir or Telaprevir Based Triple Therapy against Chronic Hepatitis C in HIV Coinfection: Real-Life Safety and Efficacy
Karin Neukam, Daniela I Munteanu, Antonio Rivero-Juárez, et al.
Page
of 8